Ray Dalio Fulgent Genetics, Inc. Transaction History

Bridgewater Associates, LP

  • $17.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$21.55 - $29.29 $62,732 - $85,263
-2,911 Reduced 13.35%
18,901 $410,000
Q4 2023

Feb 14, 2024
SELL
$23.64 - $30.27 $65,033 - $83,272
-2,751 Reduced 11.2%
21,812 $630,000
Q3 2023

Nov 13, 2023
BUY
$26.74 - $40.81 $64,229 - $98,025
2,402 Added 10.84%
24,563 $656,000
Q2 2023

Aug 11, 2023
SELL
$28.52 - $40.7 $34,879 - $49,776
-1,223 Reduced 5.23%
22,161 $820,000
Q1 2023

May 12, 2023
BUY
$29.39 - $36.27 $23,276 - $28,725
792 Added 3.51%
23,384 $730,000
Q4 2022

Feb 13, 2023
SELL
$29.23 - $40.28 $313,520 - $432,043
-10,726 Reduced 32.19%
22,592 $672,000
Q3 2022

Nov 10, 2022
BUY
$37.92 - $63.74 $52,102 - $87,578
1,374 Added 4.3%
33,318 $1.27 Million
Q2 2022

Aug 11, 2022
BUY
$47.98 - $62.75 $144,227 - $188,626
3,006 Added 10.39%
31,944 $1.74 Million
Q1 2022

May 13, 2022
BUY
$49.85 - $96.11 $345,410 - $665,946
6,929 Added 31.48%
28,938 $1.81 Million
Q4 2021

Feb 14, 2022
SELL
$77.3 - $105.0 $445,325 - $604,905
-5,761 Reduced 20.75%
22,009 $2.21 Million
Q3 2021

Nov 12, 2021
SELL
$74.87 - $110.87 $155,954 - $230,942
-2,083 Reduced 6.98%
27,770 $2.5 Million
Q2 2021

Aug 13, 2021
BUY
$66.8 - $100.45 $1.99 Million - $3 Million
29,853 New
29,853 $2.75 Million

Others Institutions Holding FLGT

# of Institutions
201
Shares Held
16.1M
Call Options Held
2.04M
Put Options Held
14K
View Full List

About Fulgent Genetics, Inc.

FLGT Quotes by TradingView
  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email